Delivery systems for antisense oligonucleotides

被引:87
作者
Garcia-Chaumont, C
Seksek, O
Grzybowska, J
Borowski, E
Bolard, J
机构
[1] Univ Paris 06, LPBC, CNRS, ESA 7033, F-75252 Paris 05, France
[2] Gdansk Univ Technol, Dept Pharmaceut Technol & Biochem, PL-80952 Gdansk, Poland
关键词
oligonucleotides; antisense; cationic lipids; liposomes; amphotericin B; gene therapy;
D O I
10.1016/S0163-7258(00)00062-0
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In vitro, the efficacy of the antisense approach is strongly increased by systems delivering oligodeoxyribonucleotides (ODNs) to cells. Up to now, most of the developed vectors favor ODN entrance by a mechanism based on endocytosis. Such is the case for particulate systems, including liposomes (cationic or non-cationic). cationic polyelectrolytes, and delivery systems targeted to specific receptors. Under these conditions, endosomal compartments may represent a dead end for ODNs. Current research attempts to develop conditions for escaping from these compartments. A new class of vectors acts by passive permeabilization of the plasma membrane. It includes peptides, streptolysin O, and cationic derivatives of polyene antibiotics. In vivo, the interest of a delivery system, up to now, has appeared limited. Development of vectors insensitive to the presence of serum seems to be a prerequisite for future improvements. (C) 2000 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:255 / 277
页数:23
相关论文
共 206 条
[1]   Perspectives in antisense therapeutics [J].
Agrawal, S ;
Iyer, RP .
PHARMACOLOGY & THERAPEUTICS, 1997, 76 (1-3) :151-160
[2]   Antisense therapeutics [J].
Agrawal, S ;
Zhao, QY .
CURRENT OPINION IN CHEMICAL BIOLOGY, 1998, 2 (04) :519-528
[3]  
AGRAWAL S, 1998, HDB EXPT PHARM
[4]   Antisense oligonucleotide delivery to cultured macrophages is improved by incorporation into sustained-release biodegradable polymer microspheres [J].
Akhtar, S ;
Lewis, KJ .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1997, 151 (01) :57-67
[5]  
Akhtar S, 1992, Trends Cell Biol, V2, P139, DOI 10.1016/0962-8924(92)90100-2
[6]   In vivo studies with antisense oligonucleotides [J].
Akhtar, S ;
Agrawal, S .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1997, 18 (01) :12-18
[7]   INTERACTIONS OF ANTISENSE DNA OLIGONUCLEOTIDE ANALOGS WITH PHOSPHOLIPID-MEMBRANES (LIPOSOMES) [J].
AKHTAR, S ;
BASU, S ;
WICKSTROM, E ;
JULIANO, RL .
NUCLEIC ACIDS RESEARCH, 1991, 19 (20) :5551-5559
[8]  
Alahari SK, 1998, J PHARMACOL EXP THER, V286, P419
[9]  
Alahari SK, 1996, MOL PHARMACOL, V50, P808
[10]  
Aliño SF, 1999, TUMOR TARGET, V4, P20